DALLAS VA RESEARCH CORPORATION

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1990

Legal Domicile

Principal Officer

JAMES P LEPAGE PHD

Phone

2148570351

Tax Period

2022-10-01 to 2023-09-30

DALLAS VA RESEARCH CORPORATION, founded in 1990, is a community nonprofit in the Medical Research sector that reported $3.2M in total revenue in fiscal year 2022. Revenue surged 59% from the prior year, signaling strong growth momentum.

Mission

THE MISSION OF THE DALLAS VA RESEARCH CORPORATION IS TO SUPPORT SCIENTIFIC RESEARCH, EDUCATION, AND REHABILITATION TO IMPROVE THE LIVES OF VETERANS AND THEIR FAMILIES.

Program Service Accomplishments

Program 1

Expenses: $2,509,587 Revenue: $3,122,714

CLINICAL RESEARCH GRANT/CONTRACT FUNDS ARE DISBURSED TO SUPPORT SPECIFIC RESEARCH PROJECTS PERFORMED UNDER THE SUPERVISION OF, OR BY, TRAINED CLINICIANS AND HEALTHCARE PROVIDERS TO FURTHER...

CLINICAL RESEARCH GRANT/CONTRACT FUNDS ARE DISBURSED TO SUPPORT SPECIFIC RESEARCH PROJECTS PERFORMED UNDER THE SUPERVISION OF, OR BY, TRAINED CLINICIANS AND HEALTHCARE PROVIDERS TO FURTHER VA-APPROVED RESEARCH AND EDUCATIONAL ACTIVITIES. WE HAVE OVER 60 ACTIVE TRIALS CONSISTING OF CLINICAL TRIALS, DEVICE TRIALS, INVESTIGATOR-INITIATED TRIALS AND DATA COLLECTION REGISTRIES. THE ORGANIZATION CONTINUES TO FOCUS ON BUSINESS DEVELOP AND PORTFOLIO DIVERSIFICATION. FEDERAL PRIME AWARDS AND OTHER FEDERAL GRANTS ARE A NEW AREA OF FOCUS THAT SHOULD ENCOURAGE NEW INVESTIGATOR INVOLVEMENT AND INTEREST.

Program 2

CONDUCT EDUCATIONAL AND TRAINING EVENTS, WEBINARS AND SEMINARS THAT SUPPORT VA APPROVED RESEARCH.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $250

Program Service Revenue $3,122,714

Investment Income $37,062

Other Revenue $21,577

TOTAL REVENUE $3,181,603

Expense Breakdown

Grants Paid $0

Salaries & Benefits $2,761,611

Fundraising Expenses $0

Program Expenses $2,509,587

Other Expenses $432,636

TOTAL EXPENSES $3,194,247

Year-over-Year Comparison

	2022	2021	Change
Revenue	$3,181,603	$1,996,257	+0.6%
Expenses	$3,194,247	$2,759,735	+0.2%
Net Income	$-12,644	$-763,478	-1.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$642,913

Total Directors

$1,588,744

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JOHN G MODRALL MD	DIRECTOR	1.00	Director	$0	$0	$390,551
JEFFERY L HASTINGS MD	SECRETARY	1.00	Officer Director	$0	$0	$329,165
RICHARD TYLER MILLER MD	DIRECTOR	1.00	Director	$0	$0	$306,783
JAMES P LEPAGE PHD	BOARD PRESID	1.00	Officer Director	$0	$0	$249,601
CYNTHIA FOSLIEN-NASH PHARMD	DIRECTOR	1.00	Director	$0	$0	$158,337
SARAH SPAIN PHD	DIRECTOR	1.00	Director	$0	$0	$154,307
MATTHEW GUSE	CEO	40.00	Officer	$64,147	$0	$64,147
WILLIAM MORRIS LAMOREAUX JD	DIRECTOR	1.00	Director	$0	$0	$0
EDDIE M JENKINS US ARMY CAPT RET	TREASURER	1.00	Officer Director	$0	$0	$0
JASON CAVE JD SES	VICE PRESIDE	1.00	Officer Director	$0	$0	$0
MICHELE PACKARD-MILAM CAE	EXECUTIVE DI	50.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	No data	No data	No data	No data
2023	$3,181,603	$3,194,247	$2,335,077	$-12,644
2022	$1,996,257	$2,759,735	$2,168,964	$-763,478
2021	$2,339,367	$2,492,150	$3,000,158	$-152,783
2020	$2,180,831	$2,801,159	$3,405,054	$-620,328
2019	$2,354,504	$3,036,994	$3,878,161	$-682,490
2018	$2,875,809	$3,531,847	$4,429,049	$-656,038